Prospective Longitudinal Multicentric Study to Evaluate Syde® Digital Endpoints in Healthy Adults
Launched by SYSNAV · Nov 6, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a digital health technology called Syde® to collect and analyze health data from healthy adults. The goal is to create a reference dataset that can help in developing and validating new digital health measures. If you participate, you will be assessed every six months over a period of two years to gather information on your health using this technology.
To be eligible for the study, you need to be between 18 and 65 years old, have a body mass index (BMI) between 17 and 35, and have a reliable internet connection at home. You will also need to agree to follow the study's procedures, which include filling out questionnaires and participating in Syde® related activities. However, the study is not open to elite athletes, pregnant women, or individuals with certain health conditions that affect walking or lower limb function. If you decide to participate, you can expect to help contribute valuable information that may lead to improvements in digital health technologies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female aged between 18 and 65 years old
- • Signed informed consent
- • Subjects with a reported BMI ≥ 17 and ≤ 35
- • Subject with unlimited internet connection at home and authorizing automatic data upload
- * Subject willing and able to comply with all study procedures including:
- • baseline data and questionnaires data entry on EDC (electronic data capture) throughout the study
- • Syde® related procedures
- • Subject confirming to be affiliated to, or beneficiary from, a social security category
- Exclusion Criteria:
- • Elite athletes (at a national level)
- • Pregnant women
- • Presence of an orthopedic, neuromuscular, or neurological pathology affecting walking gait quality or requiring a walking aid
- • Subjects reporting to have an incapacity or invalidity or to be affected by a chronic disease which can affect their activity and/or their lower limb function
- • Subjects reporting to have undergone recent surgical procedures, trauma (within 6 months), or affected by a disease or condition affecting lower limb function within 3 weeks before their inclusion
About Sysnav
Sysnav is a pioneering biotechnology company specializing in the development of innovative digital health solutions and advanced medical devices aimed at enhancing patient care and clinical outcomes. With a focus on leveraging cutting-edge technology, Sysnav aims to transform the management of chronic diseases and improve the precision of clinical trials. The company's commitment to rigorous research and development enables it to deliver robust, data-driven insights that empower healthcare professionals and patients alike. Through strategic partnerships and a dedication to scientific excellence, Sysnav is at the forefront of advancing personalized medicine and improving the overall healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rouen, , France
Bron, , France
Pontoise, , France
Vernon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported